Form 8-K - Current report:
SEC Accession No. 0000950123-06-009427
Filing Date
2006-07-26
Accepted
2006-07-26 09:13:39
Documents
4
Period of Report
2006-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y23496e8vk.htm 8-K 13669
2 EX-10.1: CREDIT AGREEMENT y23496exv10w1.txt EX-10.1 431211
3 EX-10.2: CREDIT AGREEMENT y23496exv10w2.txt EX-10.2 361808
4 GRAPHIC y23496y2349600.gif GRAPHIC 2931
  Complete submission text file 0000950123-06-009427.txt   812699
Mailing Address 2 QUAKER RD BOX 2900 POMONA NY 10970-0519
Business Address 2 QUAKER RD BOX 2900 POMONA NY 10970-0519 8453621100
BARR PHARMACEUTICALS INC (Filer) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-09860 | Film No.: 06980457
SIC: 2834 Pharmaceutical Preparations